4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-090193
Chief Financial Officer acquired 5,353 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schoch Charles Chief Financial Officer | 2025-06-25 | Grant or award | +5,353 | $4.67 | $24,999 | 43,391 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…